Skip to main content
. 2017 Mar 28;8(26):42588–42601. doi: 10.18632/oncotarget.16585

Figure 1. Relationships between GALNT6 expression and clinical features in ovarian carcinomas.

Figure 1

(A) Oncomine database (Bonome Ovarian) shows that GALNT6 is up-regulated in ovarian carcinoma (n=185) compared with normal ovarian epithelium (n=10). Fold change 2.851, p < 0.001. (B) Representative immunohistochemical staining of GALNT6 in clear cell ovarian cancer (0, +1, +2, +3). Scale bar=50 μm. Negative control in clear cell ovarian cancer does not show any specific signals (data not shown). (C) Correlation between GALNT6 expression and disease-free survival (left panel) and overall survival (right panel) in patients with endometrioid (n=20) and clear cell (n=19) ovarian carcinoma.